Alfred Oliver

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction.

Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction.

Journal: PloS one

Published: March 06, 2023

The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review.

The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review.

Journal: Palliative medicine

Published: September 22, 2022

Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review.

Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review.

Journal: Palliative medicine

Published: March 09, 2022

Development of a core outcome set to use in the research and assessment of malignant bowel obstruction: protocol for the RAMBO study.

Development of a core outcome set to use in the research and assessment of malignant bowel obstruction: protocol for the RAMBO study.

Journal: BMJ open

Published: June 30, 2020

Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.

Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.

Journal: Journal of medical imaging and radiation oncology

Published: February 13, 2020

Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.

Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.

Journal: Health technology assessment (Winchester, England)

Published: December 20, 2019

Development of a core information set for colorectal cancer surgery: a consensus study.

Development of a core information set for colorectal cancer surgery: a consensus study.

Journal: BMJ open

Published: November 16, 2019

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.

Journal: The lancet. Gastroenterology & hepatology

Published: January 03, 2019

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.

Journal: The Lancet. Respiratory medicine

Published: January 03, 2019

Core Outcomes for Colorectal Cancer Surgery: A Consensus Study.

Core Outcomes for Colorectal Cancer Surgery: A Consensus Study.

Journal: PLoS medicine

Published: August 10, 2016

Trial outcomes and information for clinical decision-making: a comparative study of opinions of health professionals.

Trial outcomes and information for clinical decision-making: a comparative study of opinions of health professionals.

Journal: Trials

Published: December 28, 2015

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.

Journal: The Lancet. Oncology

Published: June 04, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026